Brigger I - Search Results

1

Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach.

Lancelot E, Amirbekian V, Brigger I, Raynaud JS, Ballet S, David C, Rousseaux O, Le Greneur S, Port M, Lijnen HR, Bruneval P, Michel JB, Ouimet T, Roques B, Amirbekian S, Hyafil F, Vucic E, Aguinaldo JG, Corot C, Fayad ZA. Lancelot E, et al. Among authors: brigger i. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):425-32. doi: 10.1161/ATVBAHA.107.149666. Epub 2008 Feb 7. Arterioscler Thromb Vasc Biol. 2008. PMID: 18258820

2

Magnetic resonance imaging of ruptured plaques in the rabbit with ultrasmall superparamagnetic particles of iron oxide.

Durand E, Raynaud JS, Bruneval P, Brigger I, Al Haj Zen A, Mandet C, Lancelot E, Lafont A. Durand E, et al. Among authors: brigger i. J Vasc Res. 2007;44(2):119-28. doi: 10.1159/000098484. Epub 2007 Jan 10. J Vasc Res. 2007. PMID: 17215583

3

Near infrared with principal component analysis as a novel analytical approach for nanoparticle technology.

Brigger I, Chaminade P, Desmaële D, Peracchia MT, d'Angelo J, Gurny R, Renoir M, Couvreur P. Brigger I, et al. Pharm Res. 2000 Sep;17(9):1124-32. doi: 10.1023/a:1026465931525. Pharm Res. 2000. PMID: 11087046

4

The stenlying effect of high hydrostatic pressure on thermally and hydrolytically labile nanosized carriers.

Brigger I, Armand-Lefevre L, Chaminade P, Besnard M, Rigaldie Y, Largeteau A, Andremont A, Grislain L, Demazeau G, Couvreur P. Brigger I, et al. Pharm Res. 2003 Apr;20(4):674-83. doi: 10.1023/a:1023267304096. Pharm Res. 2003. PMID: 12739778

5

Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation.

Brigger I, Chaminade P, Marsaud V, Appel M, Besnard M, Gurny R, Renoir M, Couvreur P. Brigger I, et al. Int J Pharm. 2001 Feb 19;214(1-2):37-42. doi: 10.1016/s0378-5173(00)00628-1. Int J Pharm. 2001. PMID: 11282234

6

Nanoparticles in cancer therapy and diagnosis.

Brigger I, Dubernet C, Couvreur P. Brigger I, et al. Adv Drug Deliv Rev. 2002 Sep 13;54(5):631-51. doi: 10.1016/s0169-409x(02)00044-3. Adv Drug Deliv Rev. 2002. PMID: 12204596 Review.

7

Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model.

Brigger I, Morizet J, Laudani L, Aubert G, Appel M, Velasco V, Terrier-Lacombe MJ, Desmaële D, d'Angelo J, Couvreur P, Vassal G. Brigger I, et al. J Control Release. 2004 Nov 5;100(1):29-40. doi: 10.1016/j.jconrel.2004.07.019. J Control Release. 2004. PMID: 15491808

8

PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases.

Calvo P, Gouritin B, Brigger I, Lasmezas C, Deslys J, Williams A, Andreux JP, Dormont D, Couvreur P. Calvo P, et al. Among authors: brigger i. J Neurosci Methods. 2001 Oct 30;111(2):151-5. doi: 10.1016/s0165-0270(01)00450-2. J Neurosci Methods. 2001. PMID: 11595281

9

Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles.

Vauthier C, Dubernet C, Chauvierre C, Brigger I, Couvreur P. Vauthier C, et al. Among authors: brigger i. J Control Release. 2003 Dec 5;93(2):151-60. doi: 10.1016/j.jconrel.2003.08.005. J Control Release. 2003. PMID: 14636721 Review.

10

Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting.

Brigger I, Morizet J, Aubert G, Chacun H, Terrier-Lacombe MJ, Couvreur P, Vassal G. Brigger I, et al. J Pharmacol Exp Ther. 2002 Dec;303(3):928-36. doi: 10.1124/jpet.102.039669. J Pharmacol Exp Ther. 2002. PMID: 12438511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters